Related Experiment Video
Updated: Jun 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The physiological relevance of downstream effectors of p53 activity
Vinod Pant1, Sydney M Moyer1, Mitheera V1
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Abstract:
The TP53 tumor suppressor encodes a transcription factor that regulates the expression of hundreds of target genes. Previous mouse studies have identified a conserved p53-dependent transcriptional signature that includes Cdkn1A (p21), Gtse1 (G2 and S-phase expressed 1), and Eda2r. In this study, we investigated the physiological roles of these three genes, along with Bbc3 (Puma), a p53 target involved in apoptosis, as effectors of p53 activity. We generated alleles of Gtse1 and Eda2r. In contrast to previously reported Cdkn1A-null and Bbc3-null mice which do not exhibit any overt phenotypes, mice expressing N-terminal deletions of Gtse1 (Gtse1Δ7) and Eda2r (Eda2rΔ11) displayed defects in spermatogenesis and liver abnormalities, respectively. We crossed these mice to an Mdm2-deletion model that constitutively activates p53 resulting in multiple phenotypes and lethality. Notably, loss of p21 rescued the lethality associated with constitutive p53 activation in vivo, whereas the Gtse1Δ7 mutant partially rescued this effect; no rescue was observed with Eda2rΔ11 or Bbc3 loss. These findings indicate that cell cycle regulators, rather than apoptosis-related genes, are the main drivers of sustained p53-induced gastrointestinal defects and lethality.
Insights
The tumor suppressor TP53 regulates gene expression. This study found cell cycle regulators, not apoptosis genes, drive TP53-induced lethality in mice, with p21 loss rescuing the effect.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The TP53 tumor suppressor is a transcription factor regulating numerous genes.
- Previous studies identified a conserved p53-dependent transcriptional signature including Cdkn1A (p21), Gtse1, and Eda2r.
- Bbc3 (Puma) is a p53 target involved in apoptosis.
Purpose of the Study:
- To investigate the physiological roles of p53 target genes Cdkn1A (p21), Gtse1, Eda2r, and Bbc3 as effectors of p53 activity.
- To determine the contribution of these genes to p53-mediated phenotypes and lethality.
- To elucidate the mechanisms underlying TP53-induced pathologies.
Main Methods:
- Generation of novel mouse alleles for Gtse1 (Gtse1Δ7) and Eda2r (Eda2rΔ11).
- Phenotypic analysis of Gtse1Δ7 and Eda2rΔ11 mutant mice, including spermatogenesis and liver function.
- Cross-breeding mutant mice with an Mdm2-deletion model exhibiting constitutive p53 activation and lethality.
- Assessing the impact of genetic loss of p53 target genes on the lethality phenotype.
Main Results:
- Gtse1Δ7 and Eda2rΔ11 mice displayed specific defects: spermatogenesis and liver abnormalities, respectively.
- Loss of p21 fully rescued the lethality associated with constitutive p53 activation in vivo.
- The Gtse1Δ7 mutation partially rescued lethality, while Eda2rΔ11 and Bbc3 loss showed no rescue effect.
Conclusions:
- Cell cycle regulators, particularly p21, are the primary drivers of sustained p53-induced gastrointestinal defects and lethality.
- Apoptosis-related genes like Bbc3 are not the main effectors of TP53-induced lethality in this context.
- These findings highlight the critical role of cell cycle control in mediating the detrimental effects of chronic p53 activation.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

